Clinical Trial Update: Minimal Effective Concentration (EC90) of Ropivacaine [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the minimal effective concentration (EC90) of ropivacaine in axillary brachial plexus blocks with adjuncts; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anesthesia-related Conduction Block
• Axillary Brachial Plexus Block Associated Anesthesia

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Ropivacaine (Ropivacaine)

Snippet

Sponsor: Centre Hospitalier Universitaire de Besancon | Conditions: Anesthesia, Conduction, Ropivacaine | Phase 3 | Status: COMPLETED